Step-by-step lifestyle changes that can improve urologic health in men, part II: What do i tell my patients?

Primary Care - Clinics in Office Practice

Volumn 33, Issue 1, 2006, Pages 165-185

  Moyad, Mark A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; TUMOR MARKER;

CANCER MORTALITY; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; HEALTH BEHAVIOR; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HUMAN; LIFESTYLE; MEN'S HEALTH; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; UROLOGICAL CARE; VITAMIN SUPPLEMENTATION;

ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; DIET; HEALTH PROMOTION; HUMANS; LIFE STYLE; MALE; MALE UROGENITAL DISEASES; RISK FACTORS; SMOKING;

EID: 33644617496     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2005.11.003     Document Type: Review

References (170)

1. R.O. Bonow, L.A. Smaha, and S.C. Smith The international burden of cardiovascular disease: responding to the emerging epidemic Circulation 106 2002 1602 1605
2. World Heart Federation web site. Available at: http://www.world-heart. org/introduction/call_to_action.html. Accessed August 20, 2002.
3. World Health Report Mental Health: New Understanding, New Hope 2001 World Health Organization Geneva, Switzerland 144-149
4. C.M. Michaud, C.J.L. Murray, and B.R. Bloom Burden of disease: implications for future research JAMA 285 2001 535 539
5. C.J.L. Murray, and A.D. Lopez Mortality by cause for eight regions of the world: Global Burden of Disease Study Lancet 349 1997 1269 1276
6. I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215 224
7. L.C. Clark, G.F. Combs Jr., and B.W. Turnbull Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group JAMA 276 1996 1957 1963
8. C.J. Newschaffer, K. Otani, and M.K. McDonald Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort J Natl Cancer Inst 92 2000 613 621
9. P.A. Groome, S.L. Rohland, and M.D. Brundage The relative risk of early death from comorbid illnesses among prostate cancer patients receiving curative treatment J Urol 173 Suppl. 2005 53
10. L. Sandfeldt, and R.G. Hahn Cardiovascular risk factors correlate with prostate size in men with bladder outlet obstruction Br J Urol Int 92 2003 64 68
11. H. Solomon, J.W. Man, and A.S. Wierzbicki Relation of erectile dysfunction to angiographic coronary artery disease Am J Cardiol 91 2003 230 231
12. A.-B. Wirehn, S. Tornberg, and J. Carstensen Serum cholesterol and testicular cancer incidence in 45,000 men followed for 25 years Br J Cancer 92 2005 1785 1786
13. C.M. Clark, and J.H.T. Karlawish Alzheimer disease: Current concepts and emerging diagnostic and therapeutic strategies Ann Intern Med 138 2003 400 410
14. M.A. Moyad Emphasizing and promoting overall health and nontraditional treatments after a prostate cancer diagnosis Semin Urol Oncol 17 1999 119 124
15. E. Giovannucci Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature J Natl Cancer Inst 91 1999 317 331
16. L.A. Mucci, R. Tamimi, and P. Lagiou Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? Br J Urol Intl 87 2001 814 820
17. L. Chen, M. Stacewicz-Sapuntzakis, and C. Duncan Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention J Natl Cancer Inst 93 2001 1872 1879
18. M. Etminan, B. Takkouche, and F. Caamano-Isorna The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies Cancer Epidemiol Biomarkers Prev 13 2004 340 345
19. T.W.M. Boileau, Z. Liao, and S. Kim Prostate carcinogenesis in N-methyl-N-nitrosurea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets J Natl Cancer Inst 95 2003 1578 1586
20. M.A. Moyad The ABCs of nutrition and supplements for prostate cancer 2000 JW Edwards Publishing Ann Arbor, MI
21. L. Jian, C.J. Du, and A.H. Lee Do dietary lycopene and other carotenoids protect against prostate cancer? Int J Cancer 113 2005 1010 1014
22. D.A. Street, G.W. Comstock, and R.M. Salkeld Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 90 1994 1154 1161
23. L. Arab, and S. Steck Lycopene and cardiovascular disease Am J Clin Nutr 71 suppl 2000 1691S 1695S
24. T.H. Rissanen, S. Voutilainen, and K. Nyyssonen Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study Am J Clin Nutr 77 2003 133 138
25. H.D. Sesso, J.E. Buring, and E.P. Norkus Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women Am J Clin Nutr 79 2004 47 53
26. J.H. Cohen, A.R. Kristal, and J.L. Stanford Fruit and vegetable intakes and prostate cancer risk J Natl Cancer Inst 92 2000 61 68
27. A.R. Kristal, and J.W. Lampe Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence Nutr Cancer 42 2002 1 9
28. A.W. Hsing, A.P. Chokkalingam, and Y.-T. Gao Allium vegetables and risk of prostate cancer: a population-based study J Natl Cancer Inst 94 2002 1648 1651
29. C.H. van Gils, P.H.M. Peeters, and H.B. Bueno-de-Mesquita Consumption of vegetables and fruits and risk of breast cancer JAMA 293 2005 183 193
30. H.-C. Hung, K.J. Joshipura, and R. Jiang Fruit and vegetable intake and risk of major chronic disease J Natl Cancer Inst 96 2004 1577 1584
31. H.D. Sesso, J.E. Buring, and S.M. Zhang Dietary and plasma lycopene and the risk of breast cancer Cancer Epidemiol Biomarkers Prev 14 2005 1074 1081
32. B. Vastag Recent studies show limited association of fruit and vegetable consumption and cancer risk J Natl Cancer Inst 97 2005 474 475
33. D.S. Michaud, H.G. Skinner, and K. Wu Dietary patterns and pancreatic cancer risk in men and women J Natl Cancer Inst 97 2005 518 524
34. Pantuck AJ, Leppert JT, Zomorodian N, et al. Phase II study of pomegranate juice for men with rising PSA following surgery or radiation for prostate cancer. American Urologic Association Annual Meeting 2005;173(abstract 831):225-6.
35. P.J. Ferguson, E. Kurowska, and D.J. Freeman A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines J Nutr 134 2004 1529 1535
36. Q.Y. Lu, J.R. Arteaga, and Q. Zhang Inhibition of prostate cancer cell growth by an avocado extract: role of lipid-soluble bioactive substances J Nutr Biochem 16 2005 23 30
37. Borden LS Jr, Clark PE, Miller A, et al. Prospective dose-escalation trial of lycopene in men with recurrent prostate cancer following definitive local therapy. American Urologic Association Annual Meeting 2005;173(abstract 1014):275, San Antonio, Texas, May 21-26, 2005.
38. O. Kucuk, F.H. Sarkar, and W. Sakr Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy Cancer Epidemiol Biomarkers Prev 10 2001 861 868
39. M.S. Ansari, and N.P. Gupta A comparison of lycopene and orchiectomy vs. orchiectomy alone in the management of advanced prostate cancer BJU Int 92 2003 375 378
40. L. Van Horn Fiber, lipids, and coronary heart disease. Nutrition Committee advisory Circulation 95 1997 2701 2704
41. US Department of Health and Human Services Food and Drug Administration. Food labeling: health claims; soluble fiber from certain foods and coronary heart disease: final rule Fed Regist 63 1998 8103 8121
42. US Department of Health and Human Services Food and Drug Administration. Food labeling: health claims; soluble fiber from certain foods and coronary heart disease: proposed rule Fed Regist 62 1997 28234 28245
43. L. Brown, B. Rosner, and W.W. Willett Cholesterol-lowering effects of dietary fiber: a meta-analysis Am J Clin Nutr 69 1999 30 42
44. D.A. Lieberman, S. Prindiville, D.G. Weiss for the VA Cooperative Study Group 380 Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals JAMA 290 2003 2959 2967
45. M.A. Pereira, E. O'Reilly, and K. Augustsson Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies Arch Intern Med 164 2004 370 376
46. S. Liu, J. Buring, and H. Sesso A prospective study of dietary fiber intake and risk of cardiovascular disease among women J Am Coll Cardiol 39 2002 49 56
47. A. Wolk, M.E. Manson, and M.J. Stampfer Long-term intake of dietary fiber and decreased risk of coronary heart disease among women JAMA 281 1999 1998 2002
48. P. Pietinen, E.B. Rimm, and P. Korhonen Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Circulation 94 1996 2720 2727
49. E.B. Rimm, A. Ascherio, and E. Giovannucci Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men JAMA 275 1996 447 451
50. J.A. Marlett, K.B. Hosig, and N.W. Vollendorf Mechanism of serum cholesterol reduction by oat bran Hepatology 20 1994 1450 1457
51. M. Chandalia, and A. Garg Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus N Engl J Med 342 2000 1392 1398
52. K.S. Leinonen, K.S. Poutanen, and H.M. Mykkanen Rye bread decreases serum total and LDL cholesterol in men with moderately elevated serum cholesterol J Nutr 130 2000 164 170
53. J.M. Keenan, J.J. Pins, and C. Frazel Oat ingestion reduces systolic and diastolic blood pressure among moderate hypertensives: a pilot trial J Fam Pract 51 2002 369
54. The Expert Panel Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2498
55. A.E. Moreyra, A.C. Wilson, and A. Koraym Effect of combining psyllium fiber with simvastatin in lowering cholesterol Arch Intern Med 165 2005 1161 1166
56. M.T. Streppel, L.R. Arends, and P. van't Veer Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials Arch Intern Med 165 2005 150 156
57. J.A. Marlett, M.I. McBurney, J.L. Slavin for the American Dietetic Association Position of the American Dietetic Association: health implications of dietary fiber J Am Diet Assoc 102 2002 993 1000
58. A. Schatzkin, E. Lanza, D. Corle and the Polyp Prevention Trial Study Group Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas N Engl J Med 342 2000 1149 1155
59. D.S. Alberts, M.E. Martinez, and D.J. Roe Lack of effect of high-fiber cereal supplement on the recurrence of colorectal adenomas N Engl J Med 342 2000 1156 1162
60. M. Shike, L. Latkany, and E. Riedel Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial J Clin Oncol 20 2002 3592 3598
61. J.A. Eastham, E. Riedel, L. Latkany for the Polyp Prevention Trial Study Group Dietary manipulation, ethnicity, and serum PSA levels Urology 62 2003 677 682
62. C. Pelucchi, R. Talamini, and C. Galeone Fibre intake and prostate cancer risk Int J Cancer 109 2004 278 280
63. N. Tariq, D.J. Jenkins, and E. Vidgen Effect of soluble and insoluble fiber diets on serum prostate specific antigen in men J Urol 163 2000 114 118
64. A. Bylund, E. Lundin, and J.X. Zhang Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer Eur J Cancer Prev 12 2003 407 415
65. K.J. Pienta, H. Naik, and A. Akhtar Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin J Natl Cancer Inst 87 1995 348 353
66. A. Hayashi, A.C. Gillen, and J.R. Lott Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in Balb-c mice Altern Med Rev 5 2000 546 552
67. B.W. Guess, M.C. Scholz, and S.B. Strum Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study Prostate Cancer Prostatic Dis 6 2003 301 304
68. M.A. Moyad, W.A. Sakr, and D. Hirano Complementary medicine for prostate cancer: effects of soy and fat consumption Reviews in Urology 3 Suppl 2 2001 S20 S30
69. C.R. Sirtori, G. Galli, and M.R. Lovati Effects of dietary proteins on the regulation of liver lipoprotein receptors in rats J Nutr 114 1984 1493 1500
70. P. Khosla, S. Sammam, and K.K. Carrol Decreased receptor-mediated LDL catabolism in casein-fed rabbits precedes the increase in plasma cholesterol levels J Nutr Biochem 2 1991 203 209
71. S.M. Potter Soy protein and serum lipids Curr Opin Lipidol 7 1996 260 264
72. S.M. Potter Overview of possible mechanisms for the hypocholesterolemic effect of soy protein J Nutr 125 1995 606S 611S
73. US Department of Health and Human Services Food and Drug Administration. Food labeling: health claims; soy protein and coronary heart disease: proposed rule Fed Regist 63 1998 62977 63015
74. U.S Department of Health and Human Services Food and Drug Administration. Food labeling: health claims; soy protein and coronary heart disease: final rule Fed Regist 64 1999 57699 57733
75. S.M. Potter Soy protein and cardiovascular disease: the impact of bioactive components in soy Nutr Rev 56 1998 231 235
76. J.W. Anderson, B.M. Johnstone, and M.E. Cook-Newell Meta-analysis of the effects of soy protein intake on serum lipids N Engl J Med 333 1995 276 282
77. S. Zhan, and S.C. Ho Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile Am J Clin Nutr 81 2005 397 408
78. G. Peterson, and S. Barnes Genistein and biochanin-A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation Prostate 22 1993 335 345
79. O.W. Rokhlin, and M.B. Cohen Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors Cancer Lett 98 1995 103 110
80. H. Adlercreutz, S. Makela, and L. Pylkkanen Dietary phytoestrogens and prostate cancer Proc Am Assoc Cancer Res 36 1995 (abstract 41):687
81. T. Akiyama, J. Ishida, and S. Nakagawa Genistein, a specific inhibitor of tyrosine-specific protein kinases J Biol Chem 262 1987 5592 5595
82. C. Linnassier, M. Pierre, and J.B. Le Pecq Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor kinase activity Biochem Pharmacol 39 1990 187 193
83. J. Nishimura, J.S. Huang, and T.F. Deuel Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes Proc Natl Acad Sci USA 79 1982 4303 4307
84. J.B. Rubin, M.A. Shia, and P.F. Pilch Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I Nature 305 1983 438 440
85. A. Okura, H. Arakawa, and H. Oka Effect of genistein on topoisomerase activity and on the growth of (VAL 12)Ha-ras-transformed NIH 3T3 cells Biochem Biophys Res Commun 157 1988 183 189
86. T. Fotsis, M. Pepper, and H. Adlercreutz Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis J Nutr 125 1995 S790 S797
87. E. Kyle, L. Neckers, and C. Takimoto Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity Mol Pharmacol 51 1997 193 200
88. C. Nagata, S. Inaba, and N. Kawakami Inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men Nutr Cancer 36 2000 14 18
89. M.A. Moyad Lifestyle/dietary supplement partial androgen suppression and/or estrogen manipulation: A novel PSA reducer and preventive/treatment option for prostate cancer? Urol Clin N Amer 29 2002 115 124
90. M.S. Morton, A. Turkes, and L. Denis Can dietary factors influence prostatic disease? BJU Int 84 1999 549 554
91. D.M. Ornish, K.L. Lee, and W.R. Fair Dietary trial in prostate cancer: early experience and implications for clinical trial design Urology 57 Suppl 4A 2001 200 201
92. M.C. Bosland, I. Kato, and J. Melamed Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: application to efficacy assessment of soy protein Urology 57 Suppl 4A 2001 202 204
93. R.W. DeVere White, R.M. Hackman, and S.E. Soares Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer Urology 63 2004 259 263
94. K.F. Adams, C. Chen, and K.M. Newton Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial Cancer Epidemiol Biomarkers Prev 13 2004 644 648
95. D. Ornish, W. Fair, and E. Pettengill Can lifestyle changes reverse prostate cancer? J Urol 169 abstract 286 2003 74
96. A.H. Lichtenstein, L.M. Ausman, and S.M. Jalbert Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels N Engl J Med 340 1999 1933 1940
97. D.M. Tham, C.D. Gardner, and W.L. Haskell Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence J Clin Endocrinol Metab 83 1998 2223 2235
98. F. Kronenberg, and A. Fugh-Berman Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials Ann Intern Med 137 2002 805 813
99. S.C. Cunnane, S. Ganguli, and C. Menard High alpha-linolenic acid flaxseed (Linum usitatissimum): Some nutritional properties in humans Br J Nutr 69 1993 443 453
100. M.L. Bierenbaum, R. Reichstein, and T.R. Watkins Reducing atherogenic risk in hyperlipemic humans with flax seed supplementation: A preliminary report J Am Coll Nutr 12 1993 501 504
101. B.H. Arjmandi, D.A. Khan, and S. Juma Whole flaxseed consumption lowers serum LDL-cholesterol and lipoprotein(a) concentrations in postmenopausal women Nutr Res 18 1998 1203 1214
102. D.J. Jenkins, C.W. Kendall, and E. Vidgen Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: A controlled crossover trial Am J Clin Nutr 69 1999 395 402
103. L.T. Bloedon, and P.O. Szapary Flaxseed and cardiovascular risk Nut Rev 62 2004 18 27
104. A. Lemay, S. Dodin, and N. Kadri Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women Obstet Gynecol 100 2002 495 504
105. S. Dodin, A. Lemay, and H. Jacques The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial J Clin Endocrinol Metab 90 2005 1390 1397
106. F.B. Hu, and W.C. Willett Optimal diets for prevention of coronary heart disease JAMA 288 2002 2569 2578
107. R.B. Singh, M.A. Niaz, and J.P. Sharma Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian Experiment of Infarct Survival 4 Cardiovasc Drugs Ther 11 1997 485 491
108. M. de Lorgeril, S. Renaud, and N. Mamelle Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease Lancet 343 1994 1454 1459
109. M. de Lorgeril, P. Salen, and J.L. Martin Mediterrranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study Circulation 99 1999 779 785
110. C. Dabrosin, J. Chen, and L. Wang Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts Cancer Lett 185 2002 31 37
111. X. Lin, J.R. Gingrich, and W. Bao Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice Urology 60 2002 919 924
112. A.G. Schuurman, P.A. van den Brandt, and E. Dorant Association of energy and fat intake with prostate carcinoma risk: results from the Netherlands Cohort Study Cancer 86 1999 1019 1027
113. E. Giovannucci, E.B. Rimm, and G.A. Colditz A prospective study of dietary fat and risk of prostate cancer J Natl Cancer Inst 85 1993 1571 1579
114. P.H. Gann, C.H. Hennekens, and F.M. Sacks Prospective study of plasma fatty acids and risk of prostate cancer J Natl Cancer Inst 86 1994 281 286
115. W. Demark-Wahnefried, D.T. Price, and T.J. Polascik Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features Urology 58 2001 47 52
116. W. Demark-Wahnefried, C.N. Robertson, and P.J. Walther Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen Urology 63 2004 900 904
117. M.C. Morris, D.A. Evans, and J.L. Bienias Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease Arch Neurol 60 7 2003 940 946
118. H.C. Bucher, P. Hengstler, and C. Schindler N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials Am J Med 112 2002 298 304
119. P.M. Kris-Etherton, W.S. Harris, L.J. Appel for the Nutrition Committee Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 2002 2747 2757
120. W.S. Harris N-3 fatty acids and serum lipoproteins: human studies Am J Clin Nutr 65 5 Suppl 1997 1645S 1654S
121. M.C. Morris, F. Sacks, and B. Rosner Does fish oil lower blood pressure? A meta-analysis of controlled trials Circulation 88 1993 523 533
122. T.A. Mori, L.J. Beilin, and V. Burke Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease Arterioscler Thromb Vasc Biol 17 1997 279 286
123. J.H. Christensen, E. Korup, and J. Aaroe Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction Am J Cardiol 79 1997 1670 1673
124. A. Leaf, J.X. Kang, and Y.-F. Xiao Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils Circulation 107 2003 2646 2652
125. C.M. Albert, H. Campos, and M.J. Stampfer Blood levels of long-chain n-3 fatty acids and the risk of sudden death N Engl J Med 346 2002 1113 1118
126. D. Kromhout Fish consumption and sudden cardiac death JAMA 279 1998 65 66
127. B.H. Chung, S.H. Mitchell, and S.S. Zhang Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells Carcinogenesis 22 2001 1201 1206
128. P. Terry, P. Lichtenstein, and M. Feychting Fatty fish consumption and risk of prostate cancer Lancet 357 2001 1764 1766
129. W.J. Aronson, J.A. Glapsy, and S.T. Reddy Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer Urology 58 2001 283 288
130. P.D. Terry, T.E. Rohan, and A. Wolk Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence Am J Clin Nutr 77 2003 532 543
131. K. Augustsson, D.S. Michaud, and E.B. Rimm A prospective study of intake of fish and marine fatty acids and prostate cancer Cancer Epidemiol Biomark Prev 12 2003 64 67
132. M.L. Burr, A.M. Fehily, and J.F. Gilbert Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART) Lancet 2 1989 757 761
133. GISSI-Prevenzione Investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results from the GISSI-Prevenzione trial Lancet 354 1999 447 455
134. R. Marchioli, F. Barzi, and E. Bomba Early protection against sudden cardiac death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 2002 1897 1903
135. E. Guallar, M.I. Sanz-Gallardo, and P. van't Veer Mercury, fish oils, and the risk of myocardial infarction N Engl J Med 347 2002 1747 1754
136. K. Yoshizawa, E.B. Rimm, and J.J. Morris Mercury and the risk of coronary heart disease in men N Engl J Med 347 2002 1755 1760
137. M. Weil, J. Bressler, and P. Parsons Blood mercury levels and neurobehavioral function JAMA 293 2005 1875 1882
138. C.M. Albert, J.M. Gaziano, and W.C. Willett Nut consumption and decreased risk of sudden cardiac death in the physicians' health study Arch Intern Med 162 2002 1382 1387
139. J.L. Ellsworth, L.H. Kushi, and A.R. Folsom Frequent nut intake and risk of death from coronary heart disease and all causes in postmenopausal women: the Iowa Women's Health Study Nutr Metab Cardiovasc Dis 11 2001 372 377
140. L. Brown, F. Sacks, and B. Rosner Nut consumption and risk of coronary heart disease in patients with myocardial infarction FASEB J 13 1999 A4332 [abstract]
141. F.B. Hu, M.J. Stampfer, and J.E. Manson Frequent nut consumption and risk of coronary heart disease: prospective cohort study BMJ 317 1998 1341 1345
142. G.E. Fraser, and D.J. Shavlik Risk factors for all-cause and coronary heart disease mortality in the oldest-old: the Adventist Health Study Arch Intern Med 157 1997 2249 2258
143. G.E. Fraser, J. Sabate, and W.L. Beeson A possible protective effect of nut consumption on risk of coronary heart disease: the Adventist Health Study Arch Intern Med 152 1992 1416 1424
144. K.J. Helzlsouer, H.-Y. Huang, and A.J. Alberg Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer J Natl Cancer Inst 92 2000 2018 2023
145. F.B. Hu, J.E. Manson, and W.C. Willett Types of dietary fat and risk of coronary heart disease: A critical review J Am Coll Nutr 20 2001 5 19
146. M.A. Moyad An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part I Urol Oncol 23 2005 28 35
147. M.A. Moyad An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part II Urol Oncol 23 2005 36 48
148. J.A. Critchley, and S. Capewell Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review JAMA 290 2003 86 97
149. G.P. Yu, J.S. Ostroff, and Z.F. Zhang Smoking history and cancer patient survival: a hospital cancer registry study Cancer Detect Prev 21 1997 497 509
150. L.A. Plaskon, D.F. Penson, and T.L. Vaughan Cigarette smoking and risk of prostate cancer in middle-aged men Cancer Epidemiol Biomarkers Prev 12 2003 604 609
151. W.W. Roberts, E.A. Platz, and P.C. Walsh Association of cigarette smoking with extraprostatic prostate cancer in young men J Urol 169 2003 512 516
152. C. Rodriguez, L.M. Tatham, and M.J. Thun Smoking and fatal prostate cancer in a large cohort of adult men Am J Epidemiol 145 1997 466 475
153. K.J. Mukamal, K.M. Conigrave, and M.A. Mittleman Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men N Engl J Med 348 2003 109 118
154. S. Hercberg, P. Galan, and P. Preziosi The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals Arch Intern Med 164 2004 2335 2342
155. F. Meyer, P. Galan, and P. Douville Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial Int J Cancer 116 2005 182 186
156. J.W. Basler, and G.A. Piazza Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention J Urol 171 2004 S59 S63
157. M.A. Moyad, and G.S. Merrick Statins and cholesterol lowering after a cancer diagnosis: Why not? Urol Oncol 23 2005 49 55
158. J.D. Debes, R.O. Roberts, and D.J. Jacobson Inverse association between prostate cancer and the use of calcium channel blockers Cancer Epidemiol Biomarkers Prev 13 2004 255 259
159. The Hope and Hope-Too Trial Investigators Effects of long-term vitamin E supplementation on cardiovascular events and cancer JAMA 293 2005 1338 1347
160. E.R. Miller III, R. Pastor-Barriuso, and D. Dalal Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality Ann Intern Med 142 2005 37 46
161. I. Bairati, F. Meyer, and M. Gelinas A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients J Natl Cancer Inst 97 2005 481 488
162. E.A. Platz, W.C. Willet, and G.A. Colditz Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men Cancer Causes Control 11 2000 579 588
163. A. Trichopoulou, T. Costacou, and C. Bamia Adherence to a Mediterranean diet and survival in a Greek population N Engl J Med 348 2003 2599 2608
164. C.D. Morris, and S. Carson Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the US Preventive Services Task Force Ann Intern Med 139 2003 56 70
165. US Preventive Services Task Force Routine vitamin supplementation to prevent cancer and cardiovascular disease: Recommendations and rationale Ann Intern Med 139 2003 51 55
166. M.F. Leitzmann, M.J. Stampfer, and K. Wu Zinc supplement use and risk of prostate cancer J Natl Cancer Inst 95 2003 1004 1007
167. J.S. Markowitz, J.L. Donovan, and C.L. DeVane Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme JAMA 290 2003 1500 1504
168. M.K. Ang-Lee, J. Moss, and C.-S. Yuan Herbal medicines and perioperative care JAMA 286 2001 208 216
169. S. Yusuf, S. Hawken, S. Ounpuu on behalf of the INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952
170. H. Eyre, R. Kahn, R.M. Robertson for the ACS/ADA/AHA Collaborative Writing Committee Members Preventing cancer, cardiovascular disease, and diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Circulation 109 2004 3244 3255